Accelerating precision medicine with human genomic data at scale
Ovation generates high-value genomic and other omics data linked to rich longitudinal clinical data to increase drug discovery success rates across therapeutic areas.
FOR LIFE SCIENCES
Human omics data with the power to transform drug discovery and development
Ovation’s disease-specific genomic and transcriptomic data cohorts include the detailed clinical information, scale, diversity, and depth required to significantly impact biomarker discovery, target identification, and patient stratification.
Learn more
FOR CLINICAL LABS
Solutions that empower clinical labs to operate at the highest level and grow
Ovation LIMS is purpose-built to support the critical functions of molecular diagnostic laboratories. Ovation Research Network enables labs to mobilize remnant samples for human health research that expedites the discovery of new treatments.
Find out more
Featured Content
Ovation.io and Illumina launching first-of-kind GLP-1 dataset to accelerate new therapy development
Ovation.io Launches Comprehensive Research Data Set of Whole Genome Sequences and Longitudinal Clinical Records for Patients Treated with GLP-1 agonists
ONCare Alliance and Ovation.io Partner to Create a Multi-Omics Database and Biobank to Accelerate Biomarker Discovery in Oncology
FEATURED DATASET
Unlock IBD insights with comprehensive multiomics data
Expedite and de-risk the discovery of therapeutic biomarkers and targets using Ovation’s inflammatory bowel disease multiomics data. This dataset is ready for immediate access and features a diverse patient cohort with deep whole genome and RNA sequencing of both normal and diseased tissues. All patients are characterized with curated clinical data that spans the patient journey.
Ready to accelerate your research with diverse, high-value omics data?
